Mednet Launches TrialMatch for Cancer Clinical Trial Discovery
Mednet has launched TrialMatch, an AI clinical trial discovery tool for oncologists, the company announced in a press release. The tool was developed through a $2 million contract from the National Cancer Institute SBIR/STTR program.
TrialMatch lets oncologists describe a patient profile in natural language through Mednet AI. It then identifies open cancer trials based on factors including diagnosis, stage, biomarkers, and location. Results include match rationales and enrollment links.
The tool also works inside Mednet's physician community, where it surfaces enrolling trials in clinical discussions. Mednet says more than 45,000 physicians across 23 specialties use the community.
The NCI contract also funds a prospective evaluation with the SWOG Cancer Research Network. The study will assess whether AI assisted trial matching increases physician awareness of clinical trials and improves patient enrollment. TrialMatch is available now at no cost to oncologists through Mednet AI and across Mednet's physician community.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 13 OpenEvidence and Johns Hopkins Partner on Medical AI and Education Oct 13 Stryker Plans $400 Million CMR Surgical Investment Oct 13 Suvoda Expands Sofia to All New RTSM and eCOA Trials Oct 13 HealthpointCapital Invests in Surgical Software Company Ospitek Oct 13 Prologue Medicines names Stephen Harrison chief scientific officerLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
TRI Launches TRIAL.OS for Clinical Trial Management
Suvoda Updates Clinical Trial Platform With AI and Unified Access
miRoncol Health Launches AI Cancer Screening Blood Test in Ontario
Truven launches MarketScan Snapshot for healthcare data checks
Medsender Launches Agentic Referral Management for Specialty Practices
Daily AI Brief: the AI news that matters, in your inbox.